GlassScriptPhysician profile
Richard Dane Ballard
NPI 1366739054
$11,518.74
in general payments reported to CMS, 2019-2025
40 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,644 · 2020: $434 · 2021: $1,095 · 2022: $2,757 · 2023: $1,552 · 2024: $1,557 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,588.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,922.32 | 2019-2025 | Mitraclip, Xience Sierra, Triclip |
| Abiomed | $1,090.29 | 2019-2025 | Impella |
| W. L. Gore & Associates, INC. | $656.19 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo, Gore Cardioform Asd Occluder |
| Medtronic, INC. | $595.26 | 2023-2025 | Symplicity G3, In.Pact Admiral, Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $556.05 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $457.64 | 2020-2025 | General - Vascular Intervention, Eluvia, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $325.95 | 2020-2025 | Wainua, Farxiga, Lokelma |
| Penumbra, INC. | $315.13 | 2021-2024 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $274.04 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $240.88 | 2019-2024 | |
| Cook Medical LLC | $226.45 | 2020-2025 | Zilver Ptx |
| Thrombolex, INC. | $171.72 | 2025 | Bashir Endovascular Catheter |
| Inari Medical, INC. | $151.69 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.25 | 2021-2023 | Jardiance |
| Amgen INC. | $137.12 | 2020-2025 | Repatha, Repatha |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.